Stocktoria
SPRUCE BIOSCIENCES, INC. SPRB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-10-09
SPRUCE BIOSCIENCES, INC. statistics & valuation
Market cap$151.7M
P / B3.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | -1143.4% | -515.3% | — | — |
| Net margin | — | -1079.9% | -475.0% | — | — |
| FCF margin | — | 1140.3% | 330.0% | — | — |
| Return on assets | -73.5% | -117.3% | -46.1% | -53.9% | -33.4% |
| Return on equity | -91.7% | -184.0% | -62.6% | -67.4% | -38.0% |
| Debt / equity | 0.00× | 0.06× | 0.05× | 0.08× | 0.04× |
| Current ratio | 5.17 | 2.90 | 4.18 | 6.72 | 10.36 |
| Revenue growth | -100.0% | -51.3% | — | — | — |
Source: SEC EDGAR filings · CIK 0001683553 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.